earnings

Orbit rises above ‘issues,’ but Lifetime suffers 3Q loss

  ORBIT INTERNATIONAL CORP. Headquarters: Hauppauge Industry: Capital goods OTC: ORBT Reporting Date: Nov. 9, 2017 Reporting Quarter: 3Q FY2017 Quarter Ended: Sept. 30, 2017 Numbers: Net sales were reported as $5.00 million, down 8.8 percent from the $5.48 million reported for 3Q FY2016. But year-over-year reported net income rose – from $455,000 (11 cents per diluted share) to $699,000 (19 cents per diluted share) – and earnings before EBITDA held virtually steady ($507,000 and…


Applied DNA: Cotton, leather and finally making hay

By GREGORY ZELLER // It’s not quite a return to the company’s financial halcyon days, but Applied DNA Sciences may have finally turned a corner. Yes, the Stony Brook-based supply-chain, anti-counterfeiting, anti-theft and product-authentication specialist ended the second quarter of its fiscal 2017 (ended March 31) with a quarterly net loss of $3.4 million, or 13 cents per share. But it was less of a loss (barely) than the $3.5 million bite suffered in 2Q…


Slightly off, Planet Payment comes back to Earth

By GREGORY ZELLER // Planet Payment’s first quarter fell just short of analyst expectations – but the company is still on course for what would be a record-setting year. Reporting Tuesday on the results of the first quarter of its 2017 fiscal year, which ended March 31, the Long Beach-based provider of international payment, transaction-processing and currency-processing services (Nasdaq: PLPM) noted not-insignificant year-over-year drops in quarterly revenues and income. Despite the setback, company officials reaffirmed…


FalconStor shares down 30% on weak quarter, year

Melville-based data storage firm FalconStor Software (FALC) reported lower fourth quarter revenue for 2016, news that sent company shares down more than 30 percent for the week, to .43 cents, a historic low for the stock. The company reported revenue of $7.4 million for the quarter ended Dec. 31 versus $9.4 million in the year-earlier period. Its net loss was $1.2 million, or 5 cents per diluted share, compared to a net loss of $1.9…


Bottom line shines at Planet Payment

By GREGORY ZELLER // It was an up quarter to end an up year at Planet Payment Inc. Reporting Wednesday on the fourth quarter of its 2016 fiscal year, which ended Dec. 31, the Long Beach-based provider of international payment, transaction-processing and currency-processing services (Nasdaq: PLPM) noted a slight dip in year-over-year quarterly revenues – to $13.9 million, down from $15.4 million in 4Q2015 – but skyrocketing net income, which rose from $6.7 million in…


Can Chembio rebound? You bet your assays

By GREGORY ZELLER // Chembio Diagnostics Systems Inc. has significantly diversified its product portfolio, built up its global sales infrastructure and expanded its operational capacities – but the numbers just aren’t there for the Medford-based biotech. Reporting Tuesday on the results of its 2016 fourth quarter and its 2016 fiscal year, which both ended Dec. 31., the manufacturer of point-of-care diagnostic tests for infectious diseases (Nasdaq: CEMI) noted a series of down numbers, with declining…


Battling European auto thefts, and the bottom line

By GREGORY ZELLER // Holiday gift guide update: The once-mighty “Grand Theft Auto” videogame series no longer cracks most-wanted lists on the top gaming consoles. Newsflash: The real thing has also lost some luster across northwestern Europe, where Applied DNA Sciences’ SmartDNA security solutions are contributing to major vehicular-theft declines – and sending a growing gang of international grand thieves to the clink. On a “quest to protect automobiles in Scandinavia,” the Stony Brook-headquartered provider of DNA-based supply-chain,…


Planet Payment rises via Your Currency rollout

Year-over-year gains in total revenue and net income marked a strong first quarter for Planet Payment. The Long Beach-based provider of international payment, transaction-processing and currency-processing services reported earnings of $1.8 million for the quarter ended March 31, leading to adjusted earnings-per-share of 3 cents. Total revenue in the first quarter was $13.7 million, the company said Wednesday, a 13 percent increase over reported revenues in 1Q 2015. Quarterly net income also rose year-over-year, from…


BioSpecifics surges on international breakout

A high-flying international performance by its flagship product Xiaflex marked a big year for Lynbrook pharma firm BioSpecifics Technologies Corp. The biopharmaceutical company reported its fourth-quarter and full-year 2015 financials Monday, highlighted by a 62 percent jump in annual revenues and a 107 percent leap in after-tax income. The strong earnings capped “an important year of commercial growth,” according to BioSpecifics President Thomas Wegman. Wegman credited the boastful bottom line primarily to new international pipelines…


Chembio misses on drop in Latin American biz

By GREGORY ZELLER // An oversupplied Latin American market put a dent in Chembio Diagnostic’s 2015 earnings, but coming battles with the Zika virus may turn fortunes around. That was the message to investors Tuesday as CEO John Sperzel III reported the Medford firm’s financials for the year ended Dec. 31, 2015. While the company’s science – point-of-care diagnostic tests for infectious diseases – is in increasing demand, the numbers were not great. Chembio’s reported…


Diversification nips Applied DNA numbers

It wasn’t a record quarter, but Applied DNA Sciences maintained momentum and stayed true to its ongoing diversification strategy in the first quarter of Fiscal 2016. That according to James Hayward, president and CEO of the Stony Brook-based biotech firm, which this week reported results for the quarter ended Dec. 31. While Applied DNA Sciences snapped its streak of consecutive quarters with record-setting revenues at four, reported revenues were up compared to 1Q FY2015, reflecting…


Henry Schein shines in Q4, full year

An impressive rise in adjusted earnings per share highlighted 2015 fourth-quarter and year-end financials released Wednesday by Henry Schein Inc. For 4Q 2015, which ended Dec. 31, the global healthcare-products provider reported EPS of $1.67, a 7.1 percent year-over-year jump. The aggressively expanding Melville company credited the quarterly increase – and a year-end EPS of $5.96, up 9.6 percent from 2014’s per-share earnings – to strong revenues across its Dental, Medical, Animal Health and Technology…